# Royalty Pharma Sub-Manager

Royalty Pharma Sub-Manager is an Asset Manager based in New York, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** New York, United States
- **Region:** North America
- **Address:** New York, NY, United States
- **Assets under management:** Undisclosed
- **Website:** royaltypharma.com

## Regulatory record

- **CRD number:** 335070
- **SEC file number:** 801-132133
- **Registration status:** Registered
- **Reports private funds:** Yes
- **IAPD record:** https://adviserinfo.sec.gov/firm/summary/335070

## About

ROYALTY PHARMA SUB-MANAGER, LLC is an SEC-registered investment adviser in NEW YORK, NY, registered since 2025. The firm manages approximately $19.6 billion in assets. It has 91 employees and 48 investment advisers.

## Sectors

- Healthcare Services
- Private Credit

## Questions

### How does Royalty Pharma generate returns without owning equity in pharmaceutical companies?

Royalty Pharma acquires royalty interests tied to approved drugs and late-stage development candidates, receiving a contracted percentage of future product sales. This generates uncorrelated, long-duration cash flows that are not dependent on stock market valuations or acquisition events. The model avoids binary clinical trial risk by focusing on already-approved or de-risked assets, and the returns compound as drugs achieve broader reimbursement and extended patent lifespans.

### What investment stages does Royalty Pharma target, and does it fund pre-revenue companies?

Royalty Pharma operates across three stages: marketed-product royalties (approved drugs with established sales), late-stage development funding (Phase 3 or NDA-ready assets), and synthetic royalties (custom-structured financings for near-commercial candidates). The firm does fund pre-revenue companies when the underlying asset has demonstrated strong Phase 2 data and a clear regulatory path, but it structures these deals with capped returns and milestone-based payments to manage binary risk.

### How is Royalty Pharma Sub-Manager, LLC related to the public parent company?

Royalty Pharma Sub-Manager, LLC is a wholly owned subsidiary that provides investment management and advisory services to the public company and its affiliates. This entity structure is standard for externally managed publicly traded partnerships and corporations, allowing for operational and compensation flexibility while maintaining the parent company's status as the primary holder of royalty assets. Specific operational details beyond this structural context are not publicly emphasized in the firm's communications.

## Related profiles

- [Royal American Financial Advisors](https://altss.com/profile/royal-american-financial-advisors-llc)
- [RRG Capital Management](https://altss.com/profile/rrg-capital-management-llc)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/royalty-pharma-sub-manager-llc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology